Losartan

serpin family E member 1 ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30712667 The Angiotensin II type 1 receptor mediates the effects of low oxygen on early placental angiogenesis. 2019 Jan 1
2 29992039 A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. 2018 2
3 27064499 Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial. 2016 1
4 19589241 Effects of losartan on fibrinolytic parameters and von Willebrand factor in Chinese subjects with hypertension: a comparative study versus atenolol. 2009 May-Jun 2
5 17175314 Prevention of interstitial fibrosis of renal allograft by angiotensin II blockade. 2006 Dec 4
6 15194475 Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension. 2004 Jul 1 2
7 14659871 Different effects of losartan and delapril on plasma PAI-1 levels in patients with mild to moderate hypertension. 2003 Dec 1
8 17536885 Effects of losartan and delapril on the fibrinolytic system in patients with mild to moderate hypertension. 2003 2
9 11991216 Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients. 2002 Apr 3
10 12468570 ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time. 2002 Dec 2
11 11587159 Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women. 2001 Sep 1
12 11602818 Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells. 2001 Nov 1
13 10821336 Fibrinolytic function in diuretic-induced volume depletion. 2000 Apr 1
14 10368114 Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. 1999 Jun 15 3
15 10454455 Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. 1999 Aug 1
16 10604482 Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension. 1999 Nov 4